MONTI, SARA
MONTI, SARA
Dipartimento di Scienze Cliniche e di Comunità
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology
2022 A. Manfredi, G. Cassone, R. Izzo, G. Dallagiacoma, M. Felicetti, A. Cariddi, A. Berti, A. Giollo, C. Nannini, S. Bettio, S. Monti, E. Conticini, M. Govoni, L. Quartuccio, L.M. Argolini, S. Kaleci, G. Emmi, C. Dejaco, R. Padoan, L. Dagna, M. Rossini, F. Cantini, C. Montecucco, B. Frediani, S. De Vita, R. Caporali, F. Muratore, M. Sebastiani, C. Salvarani
Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes
2021 S. Monti, A. Craven, C. Klersy, C. Montecucco, R. Caporali, R. Watts, P.A. Merkel, R. Luqmani
Alveolar haemorrhage in ANCA-associated vasculitis : Long-term outcome and mortality predictors
2020 L. Quartuccio, M. Bond, M. Isola, S. Monti, M. Felicetti, F. Furini, S. Murgia, A. Berti, E. Silvestri, G. Pazzola, E. Bozzolo, P. Leccese, B. Raffeiner, S. Parisi, I. Leccese, F. Cianci, S. Bettio, P. Sainaghi, A. Ianniello, V. Ravagnani, S. Bellando Randone, P. Faggioli, C. Lomater, P. Stobbione, F. Ferro, M. Colaci, G. Alfieri, F. Carubbi, G.L. Erre, A. Giollo, N. Franzolini, M.C. Ditto, S. Balduzzi, R. Padoan, R. Bortolotti, A. Bortoluzzi, A. Cariddi, A. Padula, G. Di Scala, E. Gremese, F. Conti, S. D'Angelo, M. Matucci Cerinic, L. Dagna, G. Emmi, C. Salvarani, G. Paolazzi, D. Roccatello, M. Govoni, F. Schiavon, R. Caporali, S. De Vita
Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?
2020 E.G. Favalli, S. Monti, F. Ingegnoli, S. Balduzzi, R. Caporali, C. Montecucco
Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients
2020 E.G. Favalli, F. Conti, C. Selmi, F. Iannone, R. Bucci, F. D'Onofrio, G. Carlino, L. Santo, A. Semeraro, C. Zuccaro, S. D'Angelo, F. Atzeni, F. Marino, S. Monti, G.M. Guidelli, F.R. Spinelli, M. Biggioggero, R. Caporali
The impact of disease extent and severity detected by quantitative ultrasound analysis in the diagnosis and outcome of giant cell arteritis
2020 S. Monti, C. Ponte, C. Pereira, F. Manzoni, C. Klersy, F. Rumi, G. Carrara, A. Hutchings, W.A. Schmidt, B. Dasgupta, R. Caporali, C. Montecucco, R. Luqmani
Disease and treatment-related morbidity in young and elderly patients with granulomatosis with polyangiitis and microscopic polyangiitis
2020 A. Berti, M. Felicetti, S. Monti, A. Ortolan, R. Padoan, G. Brunori, R. Bortolotti, R. Caporali, C. Montecucco, F. Schiavon, G. Paolazzi
The role of extra-corporeal membrane oxygenation (ECMO) in the treatment of diffuse alveolar haemorrhage secondary to ANCA-associated vasculitis : report of two cases and review of the literature
2019 P. Delvino, S. Monti, S. Balduzzi, M. Belliato, C. Montecucco, R. Caporali
Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management
2019 A. Berti, R. Caporali, C. Montecucco, G. Paolazzi, S. Monti
Randomized controlled trials and real-world data : differences and similarities to untangle literature data
2018 S. Monti, V. Grosso, M. Todoerti, R. Caporali
20 years of experience with tumour necrosis factor inhibitors : what have we learned?
2018 R. Caporali, G. Crepaldi, V. Codullo, F. Benaglio, S. Monti, M. Todoerti, C. Montecucco
Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors
2018 S. Monti, M. Todoerti, V. Codullo, E.G. Favalli, M. Biggioggero, A. Becciolini, C. Montecucco, R. Caporali
How I treat idiopathic patients with inflammatory myopathies in the clinical practice
2017 L. Cavagna, S. Monti, R. Caporali, M. Gatto, L. Iaccarino, A. Doria
Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis : real-life data from the Italian LORHEN Registry
2017 S. Monti, C. Klersy, R. Gorla, P. Sarzi-Puttini, F. Atzeni, R. Pellerito, E. Fusaro, G. Paolazzi, P.A. Rocchetta, E.G. Favalli, A. Marchesoni, R. Caporali
Spinal non-Hodgkin’s lymphoma mimicking a flare of disease in a patient with ankylosing spondylitis treated with anti-TNF agents : case report and review of the literature
2016 S. Monti, N. Boffini, M. Lucioni, M. Paulli, C. Montecucco, R. Caporali
Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series
2015 S. Monti, C. Montecucco, S. Pieropan, F. Mojoli, A. Braschi, R. Caporali
Chronic pain : the burden of disease and treatment innovations
2015 S. Monti, R. Caporali
Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment : extending perspective from old to newer drugs
2015 F. DE NARD, M. Todoerti, V. Grosso, S. Monti, S. Breda, S. Rossi, C. Montecucco, R. Caporali
Rheumatoid arthritis treatment : the earlier the better to prevent joint damage
2015 S. Monti, C. Montecucco, S. Bugatti, R. Caporali
Switching from intravenous to subcutaneous formulation of abatacept : different results in a series of 21 patients
2015 S. Monti, S. Breda, V. Grosso, M. Todoerti, C. Montecucco, R. Caporali